Intellectual Property Throughout the Drug Development Lifecycle: Opportunities and Challenges

Foley Special Counsel Andrew Baluch will be speaking at the Intellectual Property Throughout the Drug Development Lifecycle Conference on July 17, 2012 in Washington, D.C. Mr. Baluch will be speaking as part of a panel titled “Post-Marketing IP Protection and Enforcement.”

This conference is a must-attend for stakeholders in the IP community. Speakers will address the intellectual property issues most important to patent litigators and in-house counsel in the pharmaceutical industry as well as the critical regulatory issues affecting the pharmaceutical industry. This focused conference addresses relevant IP topics, including patent, trademark and copyright issues throughout the drug development lifecycle—from pre-clinical development to post-marketing protection and enforcement. The subject is timely for professionals working with both brand and generic pharmaceutical companies. The implementation, maintenance, and defense of the exclusivity of these IP rights is one of the most significant legal and business issues in this era of evolving patent standards.